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There are few reports of the surgical treatment for late stage Freiburg’s disease with 
flattening of the metatarsal head and osteoarthritis. We describe the results of the surgical 
treatment of ten consecutive patients with advanced stage Freiburg’s disease (Smillie’s 
stage V), using a technique that has not been published previously.
Freiburg’s disease, or osteochondrosis of the
epiphysis of a distal metatarsal, is seen most
often in teenage girls. The second metatarsal
head is affected in 68% of cases, and the third
in 27%.1 A small number of cases are bilateral
(6.6%). Smillie2 classified the disease as: stage
I - epiphyseal fissuring; stage II - alteration of
the contour of the articular surface; stage III -
sinking of the centre of the joint surface; stage
IV - formation of a loose body; and stage V -
flattening of the metatarsal head and osteo-
arthritis. Conservative treatment is recom-
mended initially for every stage and surgery is
performed only if this fails. The management is
usually conservative in the early disease (stages
I and II), and operative in stages III, IV and V.
Several operations have been described, but
there is no consensus as to the best procedure,3
and authors have usually excluded stage V
cases, when the joint is stiff and painful with
impaired gait from their series. However, even
in this late stage, if a conservative approach
has failed surgery is indicated.
We have retrospectively examined a consec-
utive series of patients suffering from late stage
Freiburg’s disease, who did not respond to con-
servative treatment and underwent resection-
arthroplasty and implantation of a temporary
metal spacer. To our knowledge, this is the first
series of stage V Freiburg’s disease treated sur-
gically and the operative technique has not
been previously described.
Patients and Methods
Between October 2004 and June 2008 we
treated ten consecutive patients who were suf-
fering from metatarsalgia of the second (9) and
third (1) metatarsal due to stage V Freiburg’s
disease and who had not responded to conser-
vative treatment. There were nine women and
one man, with a mean age of 46.2 years (24 to
67). The left foot was affected in seven cases
and the right in three. Hallux valgus was pres-
ent in five cases, metatarsophalangeal valgus
deformity in four and interphalangeal valgism
in one. A fixed hammer deformity of the sec-
ond toe was present in one patient. In all cases,
the associated pathology was symptomatic and
received concomitant surgical treatment.
Operative technique. All patients are given pre-
operative antibiotic prophylaxis of 2 g of first
generation cephalosporin. They are also pre-
scribed low molecular weight heparin by body-
weight for 35 days after operation. The
operation is performed under regional anaes-
thesia (lepobupivacaine hydrochloride), using
a pneumatic tourniquet above the calf, inflated
to 250 mmHg. A 4 cm, slightly S-shaped, dor-
sal longitudinal incision is made, centred over
the affected metatarsophalangeal joint.
After retraction of the extensor apparatus,
a longitudinal capsulotomy is performed (Fig.
1). The collateral ligaments are released and
any bony spurs removed from the metatarsal
head. Approximately 2 mm to 3 mm of the
base of the proximal phalanx are resected
with an oscillating saw (Fig. 2). When the
appropriate joint space has been created, the
resected bone surface is made uniformly con-
cave with a motorised burr, in order to
accommodate the spacer which is convex on
the phalangeal side and concave on the meta-
tarsal aspect. The metal spacer (Button
spacer, DePuy International Ltd., Leeds,
United Kingdom) is tested for size, then
implanted and fixed with a 1.2 mm Kirschner
(K)-wire drilled firstly through the toe,
through a hole in the centre of the spacer and
onward into the metatarsal bone (Figs 3 and
4). This is followed by closure of the joint
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capsule, haemostasis and suturing. The mean tourniquet
time was 20 minutes (17 to 20). All the patients are dis-
charged the following day with a post-operative talus shoe
which has a heel wedge to unload the forefoot. This shoe
is worn for three weeks post-operatively. Full weight-bear-
ing is allowed immediately, unless there is pain. The K-
wire is removed after three weeks and the patients are
instructed to manipulate the toe gently to regain move-
ment.
The spacer is removed as a day case six months after the
initial operation under regional anaesthesia and through the
same incision. Care is taken not to damage the extensor
apparatus and to ensure an accurate reconstruction of the
metatarsophalangeal capsule. After operation, the patients
wear a talus shoe for seven days. They are instructed to start
moving the toe manually as soon as possible.
Pre-operative weight-bearing radiographs were taken in
all cases (Fig. 5). For the first 12 months the patients under-
Fig. 1
Photograph showing a dorsal metatarsophalangeal capsulotomy and
exposure of the deformed metatarsal head.
Fig. 2
Photograph showing a remodelled metatarsal head after removal of
spurs and resection.
Fig. 3
Photograph showing the spacer has been implanted and stabi-
lised with a Kirschner wire.
Fig. 4
Post-operative radiograph showing
the results of cheilectomy, resection
of the base of the proximal phalanx,
and implantation of the spacer.
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went periodic clinical and radiological review (Fig. 6),
which were subsequently carried out annually. The mean
follow-up was for 19 months (12 to 36) after removal of
the spacer and the clinical results were evaluated pre-
operatively and at follow-up according to the 100 point
AOFAS (American Orthopaedic Foot and Ankle Society)
lesser metatarsophalangeal-interphalangeal scale.4
Results
The pre-operative and post-operative scores, are shown in
Table I where 90 or more points was considered as excel-
lent; 80 to 89, good; 70 to 79, fair; and 69 points or less as
poor. Pre-operatively, all patients had pain and limitation of
metatarsophalangeal movement. No patient was lost to
follow-up. The mean scores were 39.0 (23 to 45) pre-
operatively and 83.9 (53 to 97) post-operatively. Subjec-
tively, three patients were very satisfied with the outcome
with almost complete resolution of symptoms and an excel-
lent recovery of joint function; six were much improved,
with only occasional pain which did not limit their daily
activities and one was dissatisfied. The mean results for
range of movement of the metatarsophalangeal joint were
15° pre-operatively, and 75° post-operatively (Table II). We
did not observe any complications.
Discussion
The operative treatment of late stage Freiburg’s disease
aims to relieve pain, restore metatarsophalangeal function
and re-establish the correct distribution of body weight.5
Procedures employed for advanced disease include excision
of the metatarsal head and/or base of the proximal pha-
lanx, shortening of the metatarsal, intra-articular or extra-
articular dorsiflexion osteotomy of the metatarsal head,
interposition arthroplasty with a biological or silicon
spacer and osteochondral plug transplantation.5-13
Dorsal wedge osteotomy, whether intra-7,8 or extra-
articular,9 is a standard technique with good and easily
reproduced results. However, the procedure has disadvan-
tages. Shortening of the second ray changes the weight distri-
bution and frequently leads to transfer metatarsalgia.10 Chao
et al9 described AOFAS scores comparable with our results
after a longer follow-up of 40 months, with four excellent,
seven good, and two poor or fair. However, their technique
involved a mean shortening of the metatarsal of 2.1 mm, and
one patient suffered transfer metatarsalgia as a result. Fur-
thermore, if the position of the articular surface is modified
by dorsiflexion, dorsal metatarsophalangeal joint movement
is reduced. Kinnard and Lirette7 found a mean loss of 15° of
plantar flexion and 10° of extension, and Chao et al9 a mean
reduction of 15° of flexion and 8° of extension. These results
compare favourably with our observations, although direct
comparison is difficult as they are not presented in the three
class AOFAS format for recording range of movement.
Fig. 5
Pre-operative weight-bearing radio-
graph showing advanced degener-
ative changes in the left second
metatarsophalangeal joint.
Fig. 6
Follow-up radiograph taken after
the spacer has been removed and
the joint space re-established. The
shortening of the proximal pha-
lanx is negligible.
Table I. Pre- and post-operative American Orthopaedic








  1 F 37 38 85
  2 F 53 40 85
  3 F 56 39 80
  4 F 37 40 87
  5 M 24 42 90
  6 F 39 45 95
  7 F 53 38 82
  8 F 38 43 97
  9 F 58 42 85
10 F 67 23 52
Table II. Pre- and post-operative American Orthopaedic Foot and
Ankle Society (AOFAS) scores for range of movement
Number of patients
AOFAS range of movement (°) Pre-operative Post-operative
Normal or minimal reduction > 75   0 5
Moderate reduction 30 to 74   0 3
Severe reduction < 30 10 2
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Cracchiolo et al11 observed that interpositional arthro-
plasty with a silicon spacer had not proved totally satisfac-
tory, as the operated metatarsal often cannot support the
mechanical stresses imposed on it. Many of the patients are
young, with high functional demands which risk displacing
the implant.11 They also reported cases of synovitis caused
by the foreign body, and transfer metatarsalgia. At a mean
follow-up of 37 months, their rate of failure was 12%.
The interposition of biological material, either the flexor
or extensor tendons, or joint capsule has been used with
some success. The technique has been refined to the extent
that some authors have proposed undertaking the pro-
cedure arthroscopically.12 Very good results are reported by
these authors in terms of pain relief, although recovery of
joint movement is less satisfying, probably because the
technique does not guarantee the re-establishment of an
adequate joint space.
Comparison with arthroscopic osteochondral plug trans-
plantation is more complex. This technique could be an
interesting solution, but to date, only very few preliminary
reports are available.13 The operation is limited by the tech-
nical demands of operating arthroscopically in a small joint
space which is further reduced by disease. Also, as the graft
is harvested from the knee, there may be complications at
the donor site.
Patients with late stage Freiburg’s disease have a limited
range of movement due to deformity of the articular surfaces
and a significantly reduced joint space. In our opinion, move-
ment cannot be restored by undertaking a simple debride-
ment and cheilectomy in these cases. Our technique involves
minimal resection of the base of the proximal phalanx to re-
create an adequate joint space and restore a more congruent
articulating surface. The temporary spacer maintains the dis-
tance, thereby allowing the formation and growth of a layer
of reparative tissue to cushion the joint. From these observa-
tions and histological studies after abrasion treatment for
full-thickness chondral lesions in the knee,14 it can be reason-
ably supposed that the tissue layer we observed is made of
resilient fibro-cartilage. In our experience, after six months,
this is sufficiently thick and resilient for the spacer to be
removed. In the last few years we have used metal spacers in
the treatment of hallux rigidus with good results, due to their
excellent tolerance, good mechanical properties and rela-
tively low cost. To our knowledge, a temporary metal spacer
has not been described previously for treatment of late stage
Freiburg’s disease and we consider that it has several advan-
tages over the techniques previously described. The length of
the metatarsal remains substantially unchanged which
avoids transfer metatarsalgia. The risk of rejection or break-
age of the implant is avoided, and it guarantees an adequate
space while it remains in place. The surgical technique for
implantation and removal of the spacer is easy and requires
minimal instrumentation. The longitudinal dorsal approach
gives an excellent view of both sides of the joint, which
enables the surgeon to re-model the metatarsal head and pre-
pare the phalanx. The procedure is minimally invasive and
only requires the resection of a small amount of bone, which
allows immediate weight-bearing and early return of func-
tion if a talus shoe is used post-operatively.
A possible concern with this technique is shortening of
the toe, however, any shortening we observed was minimal
(Fig. 6), and caused no functional or aesthetic problems.
Although we observed no significant reduction in the joint
space in the follow-up radiographs, we cannot exclude the
possibility of deterioration over time. A longer follow-up is
needed to establish whether our good clinical and radio-
logical results are maintained. Another disadvantage of our
technique is that a second operation, albeit minor, is
required to remove the spacer. If reliable bioreabsorbable
spacers become available, a second operation will no longer
be necessary. Our technique has some minor limitations but
we feel that the good results make it a valid alternative to
existing operations.
No benefits in any form have been received or will be received from a commer-
cial party related directly or indirectly to the subject of this article.
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